These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 12714156)
1. Association between short-term simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography. Dotani MI; Morise AP; Haque R; Jain AC; Gupta N; Gibson CM Am J Cardiol; 2003 May; 91(9):1107-9. PubMed ID: 12714156 [No Abstract] [Full Text] [Related]
2. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Lilleberg J; Nieminen MS; Akkila J; Heikkilä L; Kuitunen A; Lehtonen L; Verkkala K; Mattila S; Salmenperä M Eur Heart J; 1998 Apr; 19(4):660-8. PubMed ID: 9597417 [TBL] [Abstract][Full Text] [Related]
3. Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Huggins GS; Pasternak RC; Alpert NM; Fischman AJ; Gewirtz H Circulation; 1998 Sep; 98(13):1291-6. PubMed ID: 9751677 [TBL] [Abstract][Full Text] [Related]
4. Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease. Vita JA; Yeung AC; Winniford M; Hodgson JM; Treasure CB; Klein JL; Werns S; Kern M; Plotkin D; Shih WJ; Mitchel Y; Ganz P Circulation; 2000 Aug; 102(8):846-51. PubMed ID: 10952951 [TBL] [Abstract][Full Text] [Related]
5. [Influence of dipyridamole on coronary bypass graft flow and the phasic flow wave]. Fujiwara T; Dokou S; Inada H; Nogami A; Masaki H; Yamane N; Kanazawa S; Katsumura T; Matsuoka S; Kajiya F Kyobu Geka; 1987 Mar; 40(4):291-5. PubMed ID: 3495685 [No Abstract] [Full Text] [Related]
6. The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study. Coccia R; Spadaccio C; Foppoli C; Perluigi M; Covino E; Lusini M; Chello M Clin Ther; 2007 Aug; 29(8):1706-17. PubMed ID: 17919551 [TBL] [Abstract][Full Text] [Related]
8. Lipids: new guidelines, intensive treatment, and future directions. Jones PH Tex Heart Inst J; 2006; 33(2):180-3. PubMed ID: 16878620 [No Abstract] [Full Text] [Related]
9. Consideration of the therapeutic roles of pharmacologic agents, collateral circulation and saphenous vein bypass in coronary artery disease. Mason DT; Amsterdam EA; Miller RR; Hughes JL; Bonanno JA; Iben AB; Hurley EJ; Massumi RA; Zelis R Am J Cardiol; 1971 Nov; 28(5):608-13. PubMed ID: 4398979 [No Abstract] [Full Text] [Related]
10. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Durrington PN; Bhatnagar D; Mackness MI; Morgan J; Julier K; Khan MA; France M Heart; 2001 May; 85(5):544-8. PubMed ID: 11303007 [TBL] [Abstract][Full Text] [Related]
11. Effects of Simvastatin on the Metabolism of Fatty Acids in Combined Secondary Prevention of Coronary Heart Disease: Dosage and Gender Differences between the Effects. Kotlovskiy MY; Udut EV; Kairov GT; Fisenko VP; Udut VV Cardiovasc Hematol Disord Drug Targets; 2020; 20(2):93-107. PubMed ID: 31916523 [TBL] [Abstract][Full Text] [Related]
12. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Christenson JT Eur J Cardiothorac Surg; 1999 Apr; 15(4):394-9; discussion 399-400. PubMed ID: 10371111 [TBL] [Abstract][Full Text] [Related]
13. Primary and secondary prevention of coronary artery disease: trials of lipid lowering with statins. Pearson TA Am J Cardiol; 1998 Nov; 82(10A):28S-30S. PubMed ID: 9860353 [No Abstract] [Full Text] [Related]
14. Simvastatin: building on success. Gaw A Hosp Med; 2001 Jan; 62(1):29-32. PubMed ID: 11211458 [TBL] [Abstract][Full Text] [Related]
15. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Baller D; Notohamiprodjo G; Gleichmann U; Holzinger J; Weise R; Lehmann J Circulation; 1999 Jun; 99(22):2871-5. PubMed ID: 10359730 [TBL] [Abstract][Full Text] [Related]
16. [The influence of coronary collateral circulation on perioperative cardiac function in aorto-coronary bypass grafting]. Harada Y Nihon Kyobu Geka Gakkai Zasshi; 1988 Aug; 36(8):1352-61. PubMed ID: 3264001 [No Abstract] [Full Text] [Related]
17. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Dotani MI; Elnicki DM; Jain AC; Gibson CM Am J Cardiol; 2000 Nov; 86(10):1128-30, A6. PubMed ID: 11074212 [TBL] [Abstract][Full Text] [Related]
18. Confirmed graft flow following use of recombinant factor VIIa in coronary artery bypass grafting: a case report and literature review. Beldowicz BC; McDonald JM; Needham CS J Card Surg; 2006; 21(5):483-6. PubMed ID: 16948764 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy of coronary artery reconstruction in maintaining myocardial viability: quantitative determination of local myocardial circulation with 13NH3 myocardial positron emission tomography]. Kobayashi S; Takaba T; Kume M; Kashima T; Michihata T Nihon Kyobu Geka Gakkai Zasshi; 1996 Apr; 44(4):459-66. PubMed ID: 8666862 [TBL] [Abstract][Full Text] [Related]